Status:
COMPLETED
A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
Lead Sponsor:
Eli Lilly and Company
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
PHASE2
Brief Summary
Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa
Eligibility Criteria
Inclusion
- Must have a clinical diagnosis of Schizophrenia
- Must be at least 18 years of age and not older than 55 years of age
- Must have been stable on a dose of Abilify, Risperdal, Seroquel, or Zyprexa for the past 8 weeks
- Women of childbearing potential must be using a medically accepted means of contraception
- Must be able to swallow capsules
Exclusion
- Has serious health problems other than Schizophrenia
- Takes an antidepressant for depression
- Takes insulin for diabetes
- Have a history of alcohol or drug dependence (except for nicotine and caffeine) within the past 6 months
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00089869
Last Update
July 20 2006
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
Cerritos, California, United States
2
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician.
Chula Vista, California, United States
3
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.
Garden Grove, California, United States
4
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
San Diego, California, United States